2008
DOI: 10.3923/ijds.2009.27.33
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Goat Milk Containing Galactooligosaccharides After Supplementing the Ration with Amino Acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…The final composition of goat milk consisted of 13.2% GOS, 64.6% lactose, 14.3% glucose and 10.2% galactose. The amount of GOS produced in this work was relatively higher than the work of Foda et al (2009). This could be due to the differences in goat milk and type of b-galactosidase which was used.…”
Section: Kinetics Of Goat Milk Containing Galactooligosaccharidesmentioning
confidence: 70%
See 2 more Smart Citations
“…The final composition of goat milk consisted of 13.2% GOS, 64.6% lactose, 14.3% glucose and 10.2% galactose. The amount of GOS produced in this work was relatively higher than the work of Foda et al (2009). This could be due to the differences in goat milk and type of b-galactosidase which was used.…”
Section: Kinetics Of Goat Milk Containing Galactooligosaccharidesmentioning
confidence: 70%
“…The amount of GOS produced in this work was relatively higher than the work of Foda et al . (). This could be due to the differences in goat milk and type of β‐galactosidase which was used.…”
Section: Resultsmentioning
confidence: 97%
See 1 more Smart Citation
“…References: a: Prenosil et al, ; b: Fischer & Kleinschmidt, ; c: Mause, ; d: Jovanovic‐Malinovska, Fernandes, Winkelhausen, & Fonseca, ; e: Valero, ; f: Rodriguez‐Colinas et al, ; g: Gosling et al, ; h: Rodriguez‐Colinas, Poveda, Jimenez‐Barbero, Ballesteros, & Plou, ; i: Cho et al, ; j: Hellerová & Čurda, ; k: Pocedičová et al, ; l: Splechtna et al, ; m: Vasiljevic & Jelen, ; n: Lopez Leiva & Guzman, ; o: Wierzbicki & Kosikowski, ; p: Sen, Nath, Bhattacharjee, Chowdhury, & Bhattacharya, ; q: Sen, Bhattacharjee, & Bhattacharya, ; r: Geiger et al, ; s: Rustom, Foda, & López‐Leiva, ; t: Hugo, Bruno, & Golowczyc, ; u: Golowczyc et al, ; v: Sabater, Olano, Prodanov, Montilla, & Corzo, ; w: Manucci, ; x: Adamczak, Charubin, & Bednarski, ; y: Foda & Lopez‐Leiva, ; z: Padilla et al, ; aa: Sangwan et al., ; ab: Lisboa et al., ; ac: Song et al., ; ad: Čurda, Rudolfová, Štětina, & Dryák, ; ae: Frenzel et al., ; af: Chen et al., ; ag: Zerge, ; ah: Lorenzen et al., ; ai: Pruksasri & Supee, ; aj: Rodriguez‐Colinas et al., ; ak: Mozaffar et al., ; al: Bakken, Hill, & Amundson, ; am: Foda, Kholif, & Kholif, ; an: Burvall et al., ; ao: Greenberg & Mahoney, ; ap: Roy et al., ; aq: Yadav et al., , ar: Liu et al., , as: Lisboa et al., , at: Roberts & Pettinati, , au: Ruiz‐Matute et al., , av: Patent No. EP 0 323 201 B1, 1990, aw: Goulas et al., .…”
Section: Gos Synthesis In Milk and Wheymentioning
confidence: 99%
“…These glycans function as competitors for receptors and may prevent infection by inhibiting pathogen binding to host epithelial cells. Such glycans are usually stable at room temperature and are intrinsically sweet tasting [33,34]. These features may allow them to be economically distributed as a drink for use by the general population; glycan supplements would be particularly beneficial to infants, who are more susceptible to infections.…”
Section: Blood Group Carbohydrates In Hmos Protect Infants From Infecmentioning
confidence: 99%